DiPerna Paul reported grant involving 150,000 derivative units of Modular Medical, Inc. at $0.00 for $0 on Oct 29, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
See Remarks
See Remarks
Filed Nov 9, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
150,000Option to purchase common stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
150,000Direct
Trade date
Oct 29, 2026Grant
Filed
Nov 9, 2026, 9:57 PM ET12-day reporting delay
Accession
0001213900-26-117704Code A · Transaction 396656
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 12 calendar days after the transaction date.

MODD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MODD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 17, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +126%1w ago +11%1d ago +11%
Returns since7d30d90d180d1y

Footnotes in full

F1: This option shall vest as to 1/3rd of the shares subject to the option on October 29, 2027 and as to 1/36th of the shares subject to the option on a monthly basis thereafter. F2: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."